HIF1A and neoplasm: HIF1α upregulates the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) to induce angiogenesis in the TME as well as inducing glucose transporters GLUT1 and GLUT3 to enhance tumor cell glycolytic metabolism [133].